Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

85
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
85
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

123
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
123
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

114
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
114
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

107
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
107
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

111
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
111
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

214
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Uncertainty Quantification in Molecular Machine Learning for Property Predictions under Data Shifts.

Journal of chemical information and modeling·2026
Same author

Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug Discovery.

Journal of chemical information and modeling·2025
Same author

Scaffold Hopping with Generative Reinforcement Learning.

Journal of chemical information and modeling·2025
Same author

Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 Inflammasome.

Journal of medicinal chemistry·2024
Same author

UNIQUE: A Framework for Uncertainty Quantification Benchmarking.

Journal of chemical information and modeling·2024

Related Experiment Video

Updated: Aug 19, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K

Multispecies Machine Learning Predictions of In Vitro Intrinsic Clearance with Uncertainty Quantification Analyses.

Raquel Rodríguez-Pérez1, Markus Trunzer1, Nadine Schneider1

  • 1Novartis Institutes for Biomedical Research, Novartis Campus, BaselCH-4002, Switzerland.

Molecular Pharmaceutics
|November 28, 2022
PubMed
Summary

Machine learning accurately predicts drug metabolic stability by modeling intrinsic clearance (CLint) across multiple species. This approach enhances compound prioritization by minimizing prediction errors and quantifying uncertainty.

Keywords:
deep learningexperimental variabilitygraph neural networksintrinsic clearancemachine learningmetabolic stabilitymultitask learninguncertainty quantification

More Related Videos

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Aug 19, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K
Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
10:16

Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds

Published on: June 6, 2015

9.1K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Computational chemistry and drug discovery
  • Pharmacokinetics and drug metabolism

Background:

  • Optimizing metabolic stability is crucial in pharmaceutical research to prevent rapid drug elimination.
  • Intrinsic clearance (CLint) in liver microsomes or hepatocytes is a key metric for lead optimization.

Purpose of the Study:

  • To develop machine learning models for predicting intrinsic clearance (CLint) and metabolic stability from compound structures.
  • To create a multispecies machine learning model for simultaneous CLint prediction across six species.

Main Methods:

  • A multitask (MT) learning architecture, specifically a graph neural network (MT-GNN), was employed.
  • An ensemble of 10 MT-GNN models was developed and prospectively evaluated.
  • Systematic quantification of uncertainty in experimental values and model predictions was performed.

Main Results:

  • The MT-GNN model achieved geometric mean fold errors consistently below 2-fold.
  • High precision was achieved in predicting high (>300 μL/min/mg) and low (<100 μL/min/mg) CLint compounds (75-97% precision).
  • MT-GNN model performance approached the experimental variability of in vitro clearance assays.

Conclusions:

  • The developed multispecies deep learning model significantly improves CLint predictions.
  • Uncertainty quantification aids in identifying reliable predictions and facilitates informed decisions in early drug development.
  • This approach supports efficient compound prioritization by accurately assessing metabolic stability.